HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

STE: Steris Corp - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
STERIS CORP (NYSE)
STE 33.06 0.32 (0.98%) Vol.  209,975 16:01 ET
STERIS Corporation is a leading provider of infection prevention, contamination prevention, and surgical support systems, products, services, and technologies to healthcare, scientific, research, and industrial Customers throughout the world. The Company has over 4,000 Associates (employees) worldwide, including more than 1,200 direct sales, service, and field support personnel. Customer Support facilities are located in major global market centers with manufacturing operations in theUnited States, Canada, Germany, and Finland.

 General Information
STERIS CORP
5960 Heisley Road
Mentor, OH 44060-1834
Phone: 440-354-2600
Fax: 440-639-4457
Web: www.steris.com
Email: InvestorRelations@steris.com
 
Industry MED/DENTAL-SUPP
Sector: Medical
 
Fiscal Year End March
Last Reported Quarter 09/30/09
Next EPS Date 01/26/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 32.74
52 Week High 35.42
52 Week Low 19.20
Beta 0.68
20 Day Moving Average 526,875.56
Target Price Consensus 37.25
 
 % Price Change
4 Week 1.18
12 Week 10.18
YTD 33.24
 % Price Change Relative to S&P 500
4 Week 0.08
12 Week 3.87
YTD 10.27
 Share Information
Shares Outstanding (millions) 58.60
Market Capitalization (millions) 1,865.24
Short Ratio 11.11
Last Split Date 08/25/1998
 Dividend Information
Dividend Yield 1.38%
Annual Dividend $0.44
Payout Ratio 0.22
Change in Payout Ratio 0.08
Last Dividend Payout / Amount 11/20/2009 / $2.11

 EPS Information
Current Quarter EPS Consensus Estimate 0.47
Current Year EPS Consensus Estimate 1.95
Estimated Long-Term EPS Growth Rate -
Next EPS Report Date 01/26/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 3.00
30 Days Ago 3.00
60 Days Ago 3.00
90 Days Ago 3.00

 Fundamental Ratios
 P/E
Current FY Estimate: 16.32
Trailing 12 Months: 15.99
PEG Ratio -
 EPS Growth
vs. Previous Year 12.50%
vs. Previous Quarter 25.58%
 Sales Growth
vs. Previous Year -2.75%
vs. Previous Quarter: 10.82%
 Price Ratios
Price/Book 2.44
Price/Cash Flow 10.74
Price / Sales 1.48
 ROE
09/30/09 16.07
06/30/09 15.57
03/31/09 15.85
 ROA
09/30/09 9.73
06/30/09 9.34
03/31/09 9.35
 Current Ratio
09/30/09 -
06/30/09 3.30
03/31/09 2.74
 Quick Ratio
09/30/09 -
06/30/09 2.47
03/31/09 2.09
 Operating Margin
09/30/09 9.32
06/30/09 9.01
03/31/09 8.82
 Net Margin
09/30/09 -
06/30/09 13.60
03/31/09 12.82
 Pre-Tax Margin
09/30/09 -
06/30/09 13.60
03/31/09 12.82
 Book Value
09/30/09 -
06/30/09 13.04
03/31/09 12.28
 Inventory Turnover
09/30/09 -
06/30/09 5.19
03/31/09 5.07
 Debt-to-Equity
09/30/09 -
06/30/09 0.27
03/31/09 0.29
 Debt to Capital
09/30/09 -
06/30/09 21.57
03/31/09 22.64

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research